Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Bendamustine, Gemcitabine and Dexamethasone Chemotherapy Is Effective Salvage and Stem-Cell Mobilization Regimen in Patients with Relapsed or Refractory Hodgkin Lymphoma — Early Results of the Polish Lymphoma Research Group Study

Ewa Paszkiewicz-Kozik, Jan Zaucha, MD PhD, Agata Tyczyńska, MD, Marcin Szymanski, MD, Lukasz Targonski, MD, Joanna Drozd-Sokolowska, MD PhD, Elżbieta Wojciechowska-Lampka, MD, Joanna Tajer, MD PhD, Pawel Kurczab, MD, Joanna Romejko-Jarosinska, MD PhD, Michal Osowiecki, MD, Jan Walewski, MD PhD

Blood (2017) 130 (Supplement 1): 4098.

https://doi.org/10.1182/blood.V130.Suppl_1.4098.4098

Published: 2017

Journal Articles

Subcutaneous Compared to Intravenous Administration of Rituximab Plus CHOP in Patients with Diffuse Large B-Cell Lymphoma — a Study By the Polish Lymphoma Research Group

Ewa Paszkiewicz-Kozik, Monika Dlugosz-Danecka, MD PhD, Paweł J. Robak, MD, Elżbieta Wojciechowska-Lampka, MD, Monika Swierkowska-Czeneszew, MD, Joanna Tajer, MD PhD, Joanna Romejko-Jarosinska, MD PhD, Katarzyna Domanska-Czyz, MD, Marcin Szymanski, MD, Marta Morawska, MD, Lukasz Targonski, MD, Michal Osowiecki, MD, Beata Ostrowska, MDPhD, Anna Paulina Dabrowska-Iwanicka, MD PhD, Jan Walewski, MD PhD

Blood (2017) 130 (Supplement 1): 5217.

https://doi.org/10.1182/blood.V130.Suppl_1.5217.5217

Published: 2017

Journal Articles

DA-EPOCH-R Is an Effective Regimen in High Grade B-Cell Lymphoma Defined By Cell-of-Origin, Karyotype and BCL2 / MYC / BCL6 Status and Expression

Blood (2016) 128 (22): 1754.

https://doi.org/10.1182/blood.V128.22.1754.1754

Published: 2016

Journal Articles

Secondary Central Nervous System (CNS) Involvement in Patients Diagnosed with Diffuse Large B-Cell Lymphoma (DLBCL) during the First Line R-CHOP Treatment and after the End of Treatment

Joanna Romejko-Jarosinska, MD PhD, Michal Osowiecki, MD, Beata Ostrowska, MD PhD, Martyna Kotarska, MD, Katarzyna Domanska-Czyz, MD, Marcin Szymanski, MD, Lukasz Targonski, MD, Anna Borawska, MD PhD, Agnieszka Druzd-Sitek, MD PhD, Ewa Paszkiewicz-Kozik, MD PhD, Lidia Poplawska, Grzegorz Rymkiewicz, MD PhD, Jan Walewski, MD PhDProf

Blood (2015) 126 (23): 5040.

https://doi.org/10.1182/blood.V126.23.5040.5040

Published: 2015

Journal Articles

The Role of the Rituximab Partner Chemotherapy Regimen In Young Patients with Good-Prognosis Diffuse Large B-Cell Lymphoma (DLBCL): Results of the 6-Year Follow-up of the Mint Study of the Mabthera International Trial (MInT) Group.

Niels Murawski, MD, Evelyn Kuhnt, Sandra Grass, MD, Wolfgang Hiddemann, MD, Eva Cavallin-Stahl, MD, Georg Hess, MD, Mathias Witzens-Harig, Ingrid Vasova, MD, Ulrich Jäger, MD, Michal Osowiecki, MD, Scott North, MD, Ruth Pettengell, FRACP, PhD, Viola Pöschel, Markus Löffler, Michael Pfreundschuh, MD

Blood (2010) 116 (21): 2826.

https://doi.org/10.1182/blood.V116.21.2826.2826

Published: 2010

Journal Articles

Predictive Value of Bcl-2 and Bcl-6 Protein Expression in Diffuse Large B-Cell Lymphoma Patients from a Single Institution.

Ewa Paszkiewicz-Kozik, MD, Olga Mioduszewska, MD PhD, Irena Federowicz, MD PhD, Ewa Kraszewska, Elzbieta Kulczycka, PhD, Katarzyna Domanska-Czyz, MD, Beata Ostrowska, MD, Joanna Romejko-Jarosinska, MD, Michal Osowiecki, MD, Jan A. Walewski, MD PhD

Blood (2004) 104 (11): 4546.

https://doi.org/10.1182/blood.V104.11.4546.4546

Published: 2004

NARROW

Bendamustine, Gemcitabine and Dexamethasone Chemotherapy Is Effective Salvage and Stem-Cell Mobilization Regimen in Patients with Relapsed or Refractory Hodgkin Lymphoma — Early Results of the Polish Lymphoma Research Group Study

Subcutaneous Compared to Intravenous Administration of Rituximab Plus CHOP in Patients with Diffuse Large B-Cell Lymphoma — a Study By the Polish Lymphoma Research Group

DA-EPOCH-R Is an Effective Regimen in High Grade B-Cell Lymphoma Defined By Cell-of-Origin, Karyotype and BCL2 / MYC / BCL6 Status and Expression

Secondary Central Nervous System (CNS) Involvement in Patients Diagnosed with Diffuse Large B-Cell Lymphoma (DLBCL) during the First Line R-CHOP Treatment and after the End of Treatment

The Role of the Rituximab Partner Chemotherapy Regimen In Young Patients with Good-Prognosis Diffuse Large B-Cell Lymphoma (DLBCL): Results of the 6-Year Follow-up of the Mint Study of the Mabthera International Trial (MInT) Group.

Predictive Value of Bcl-2 and Bcl-6 Protein Expression in Diffuse Large B-Cell Lymphoma Patients from a Single Institution.

Email alerts

ASH Publications

American Society of Hematology

Bendamustine, Gemcitabine and Dexamethasone Chemotherapy Is Effective Salvage and Stem-Cell Mobilization Regimen in Patients with Relapsed or Refractory Hodgkin Lymphoma — Early Results of the Polish Lymphoma Research Group Study

Subcutaneous Compared to Intravenous Administration of Rituximab Plus CHOP in Patients with Diffuse Large B-Cell Lymphoma — a Study By the Polish Lymphoma Research Group

DA-EPOCH-R Is an Effective Regimen in High Grade B-Cell Lymphoma Defined By Cell-of-Origin, Karyotype and BCL2 / MYC / BCL6 Status and Expression

Secondary Central Nervous System (CNS) Involvement in Patients Diagnosed with Diffuse Large B-Cell Lymphoma (DLBCL) during the First Line R-CHOP Treatment and after the End of Treatment

The Role of the Rituximab Partner Chemotherapy Regimen In Young Patients with Good-Prognosis Diffuse Large B-Cell Lymphoma (DLBCL): Results of the 6-Year Follow-up of the Mint Study of the Mabthera International Trial (MInT) Group.

Predictive Value of Bcl-2 and Bcl-6 Protein Expression in Diffuse Large B-Cell Lymphoma Patients from a Single Institution.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only